Association of Combinations of Polymorphisms in Fibroblast Growth Factor Receptor 2 Gene with Breast Cancer among Various Ethnic Groups

被引:0
|
作者
Aitkhozhina, N. A. [1 ]
Khanseitova, A. K. [1 ]
Nigmatova, V. G. [1 ]
Neupokoeva, A. S. [1 ]
Sharafutdinova, D. A. [1 ]
Ashirbekov, E. E. [1 ]
Favorov, A. V. [2 ,3 ,4 ]
Balmukhanov, T. S. [1 ]
机构
[1] Aitkhozhin Inst Mol Biol & Biochem, Alma Ata 050012, Kazakhstan
[2] Russian Acad Sci, Vavilov Inst Gen Genet, Moscow 119991, Russia
[3] Johns Hopkins Sch Med, Baltimore, MD 21205 USA
[4] Inst Genet & Select Ind Microorganisms, Moscow 117545, Russia
关键词
breast cancer; polymorphism; FGFR2; gene; APSampler; Kazakhstan; GENOME-WIDE ASSOCIATION; MULTIPLE-SCLEROSIS; AFRICAN-AMERICAN; FGFR2; SUSCEPTIBILITY; POPULATION; VARIANTS; WOMEN; RISK;
D O I
10.1134/S1022795417090022
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
A search for association of polymorphisms in loci rs2981582, rs2420946, rs17102287, rs1219648, rs2981578, and rs17542768 in fibroblast growth factor receptor 2 (FGFR2) gene was performed using the "case-control" method among the major ethnic groups of Kazakhstan. Restriction fragments length polymorphism analysis of DNA obtained from 495 Kazakh and 195 Russian women with breast cancer (BC) revealed no statistically significant differences compared with the control group (190 Kazakhs, 170 Russians). An assessment of combination associations of alleles and genotypes (patterns) with BC was performed using the APSampler algorithm. Association of risk type (OR > 1.4; P-Fischer < 0.05; P-permutation < 0.05) in the Kazakh group identified two patterns, including allele C at site rs2420946, while the T allele was present in four protective patterns (OR < 0.70). No significant association of the examined polymorphisms with BC risk in the Russian group was revealed.
引用
收藏
页码:1042 / 1047
页数:6
相关论文
共 50 条
  • [1] Association of combinations of polymorphisms in fibroblast growth factor receptor 2 gene with breast cancer among various ethnic groups
    N. A. Aitkhozhina
    A. K. Khanseitova
    V. G. Nigmatova
    A. S. Neupokoeva
    D. A. Sharafutdinova
    E. E. Ashirbekov
    A. V. Favorov
    T. S. Balmukhanov
    Russian Journal of Genetics, 2017, 53 : 1042 - 1047
  • [2] Association between fibroblast growth factor receptor-2 gene polymorphism and risk of breast cancer in Chinese populations: A HuGE review and meta-analysis
    Yang, Yong-Bin
    Zhao, Zhan-Xue
    Huang, Wei
    Liu, Hui
    Tan, Yan-Li
    Wang, Wei-Ming
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2016, 12 (02) : 543 - 549
  • [3] Fibroblast Growth Factor Receptor 2 Signaling in Breast Cancer
    Lei, Haipeng
    Deng, Chu-Xia
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2017, 13 (09): : 1163 - 1171
  • [4] Case-Control Study on the Fibroblast Growth Factor Receptor 2 Gene Polymorphisms Associated with Breast Cancer in Chinese Han Women
    Liu, Chun-Lian
    Hu, Xiao-Ping
    Guo, Wei-Dong
    Yang, Li
    Dang, Jie
    Jiao, Hai-Yan
    JOURNAL OF BREAST CANCER, 2013, 16 (04) : 366 - 371
  • [5] Assessing interactions between the associations of fibroblast growth factor receptor 2 common genetic variants and hormone receptor status with breast cancer risk
    Wang, Hong
    Yang, Ziang
    Zhang, Hongwei
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 137 (02) : 511 - 522
  • [6] Fibroblast growth factor receptor 2 gene (FGFR2) rs2981582T/C polymorphism and susceptibility to breast cancer in Saudi women
    AlRaddadi, Rawya Ibrahim Rabeh
    Alamri, Razan Jamaan Nafaa
    Shebli, Weam Talal Yehya
    Fallatah, Emad Ibrahim Yagoub
    Alhujaily, Ahmed Safar
    Mohamed, Hiba Salaheldin
    Alotibi, Mohammad Kdaimes H.
    SAUDI JOURNAL OF BIOLOGICAL SCIENCES, 2021, 28 (11) : 6112 - 6115
  • [7] Prognostic implications of fibroblast growth factor receptor 4 polymorphisms in primary breast cancer
    Wei, Wei
    You, Zilong
    Sun, Shanshan
    Wang, Yuhang
    Zhang, Xianyu
    Pang, Da
    Jiang, Yongdong
    MOLECULAR CARCINOGENESIS, 2018, 57 (08) : 988 - 996
  • [8] Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study
    Andersen, Shaneda Warren
    Trentham-Dietz, Amy
    Figueroa, Jonine D.
    Titus, Linda J.
    Cai, Qiuyin
    Long, Jirong
    Hampton, John M.
    Egan, Kathleen M.
    Newcomb, Polly A.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2013, 20 (03): : 354 - 358
  • [9] Association of Fibroblast Growth Factor Receptor 4 Genetic Polymorphisms With the Development of Uterine Cervical Cancer and Patient Prognosis
    Chen, Tze-Ho
    Yang, Shun-Fa
    Liu, Yu-Fan
    Lin, Wea-Lung
    Han, Chih-Ping
    Wang, Po-Hui
    REPRODUCTIVE SCIENCES, 2018, 25 (01) : 86 - 93
  • [10] Gene-based analysis of the fibroblast growth factor receptor signaling pathway in relation to breast cancer in African American women: the AMBER consortium
    Ruiz-Narvaez, Edward A.
    Haddad, Stephen A.
    Lunetta, Kathryn L.
    Yao, Song
    Bensen, Jeannette T.
    Sucheston-Campbell, Lara E.
    Hong, Chi-Chen
    Haiman, Christopher A.
    Olshan, Andrew F.
    Ambrosone, Christine B.
    Palmer, Julie R.
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 155 (02) : 355 - 363